3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production. [PDF]
Li Z, Wu Y, Li H, Li W, Tan J, Qiao W.
europepmc +1 more source
Promyelocytic leukemia protein is required for gain of function by mutant p53.
Mutations in the p53 tumor suppressor are the most common genetic events in human cancer. These mutations not only result in a loss of wild-type p53 activity, but can also lead to a gain of new oncogenic properties.
S. Haupt +7 more
semanticscholar +1 more source
Manipulation of Promyelocytic Leukemia Protein Nuclear Bodies by Marek's Disease Virus Encoded US3 Protein Kinase. [PDF]
Liao Y, Lupiani B, Reddy SM.
europepmc +1 more source
Acute promyelocytic leukemia (APL) accounts for 5–15% of acute myeloid leukemia cases. It is typically characterized by the (15;17) chromosomal translocation, producing the pathogenic retinoic acid receptor (RAR) alpha/promyelocytic leukemia (PML) fusion
Bojana Lucic +20 more
doaj +1 more source
Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein. [PDF]
Li Y +9 more
europepmc +1 more source
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients [PDF]
BACKGROUND: Promyelocytic leukemia (PML) tumor suppressor gene plays a key role in acute PML pathogenesis but its involvement in pathogenesis and prognosis of solid cancers has not been defined yet.
Adamo, V +15 more
core
Background Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), characterized by a fusion between the PML and RARA genes and by a block in the myeloid maturation at the promyelocytic stage.
Xiangfu Zhong +6 more
doaj +1 more source
Molecular mechanisms in haematological malignancies [PDF]
Haematopoiesis requires the constant production of large numbers of peripheral blood cells. This process is under tight control of transcription factor networks as well as cytokines, growth factors and hormones.
Avellino, Roberto +2 more
core
Retraction for Bischof et al., "Human Papillomavirus Oncoprotein E7 Targets the Promyelocytic Leukemia Protein and Circumvents Cellular Senescence via the Rb and p53 Tumor Suppressor Pathways". [PDF]
Bischof O, Nacerddine K, Dejean A.
europepmc +1 more source

